




In Other News
AI Prostate Cancer Test Added to NCCN Guidelines for Post-Surgery Recurrence
BioGiox and Labnovation Showcase Molecular Diagnostics and HbA1c Testing at MEDICA 2026
BIOTYPE Introduces Diagnostics and Cancer Profiling Assays at MEDICA 2026
i-SENS Showcasing Point-of-Care Diagnostics and Glucose Monitoring
AI Predicts Kidney Stone Composition From Routine Urine Tests
AMP 2026 Underscores Molecular Testing’s Role in Precision Medicine for Women’s Health
Organ-on-Chip System Offers Insights Into Tumor Interactions and Treatment Response
Organ-on-Chip System Offers Insights Into Tumor Interactions and Treatment Response
Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum
AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026
Updated PSA Testing Guidelines Support Early Prostate Cancer Detection
AMP 2026 Highlights Advances in Molecular Testing for Pediatric Diseases
Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study
New Training Approach Helps AI Distinguish Neighboring Cells in Tissue
Genomic Studies Investigate Treatment Response and Inherited Risk in Sarcoma
MEDICA 2026 Puts Start-Ups in the Spotlight
MEDICA 2026 Brings the Hospital of the Future to Life
Serial Blood Samples Reveal Leukemia’s Evolution Decades Before Diagnosis
Antibody-Free Blood Test Detects Rheumatic Heart Disease Biomarker
Liquid Biopsy Expands Insights Into Treatment Response and Tumor Alterations
Genomic Sequencing Identifies Actionable Findings to Guide Rare Disease Management
Blood and Spinal Fluid Biomarker May Help Track Early Huntington’s Disease
Combined Blood Tests Help Clarify Colorectal Cancer Recurrence Risk







